<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38979186</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>BioMapAI: Artificial Intelligence Multi-Omics Modeling of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.06.24.600378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.06.24.600378</ELocationID><Abstract><AbstractText>Chronic diseases like ME/CFS and long COVID exhibit high heterogeneity with multifactorial etiology and progression, complicating diagnosis and treatment. To address this, we developed BioMapAI, an explainable Deep Learning framework using the richest longitudinal multi-'omics dataset for ME/CFS to date. This dataset includes gut metagenomics, plasma metabolome, immune profiling, blood labs, and clinical symptoms. By connecting multi-'omics to asymptom matrix, BioMapAI identified both disease- and symptom-specific biomarkers, reconstructed symptoms, and achieved state-of-the-art precision in disease classification. We also created the first connectivity map of these 'omics in both healthy and disease states and revealed how microbiome-immune-metabolome crosstalk shifted from healthy to ME/CFS. Thus, we proposed several innovative mechanistic hypotheses for ME/CFS: Disrupted microbial functions - SCFA (butyrate), BCAA (amino acid), tryptophan, benzoate - lost connection with plasma lipids and bile acids, and activated inflammatory and mucosal immune cells (MAIT, &#x3b3;&#x3b4;T cells) with INF&#x3b3; and GzA secretion. These abnormal dynamics are linked to key disease symptoms, including gastrointestinal issues, fatigue, and sleep problems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Ruoyun</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8107-3452</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Connecticut Health Center, Farmington, Connecticut, USA. 06030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldwell</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2348-6352</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernon</LastName><ForeName>Suzanne D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-5241-8914</Identifier><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, Utah, USA. 84102.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozhaya</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunter</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5203-7409</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Connecticut Health Center, Farmington, Connecticut, USA. 06030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9546-9922</Identifier><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, Utah, USA. 84102.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unutmaz</LastName><ForeName>Derya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8898-6633</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Julia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5534-7023</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory, Farmington, Connecticut, USA. 06032.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR078634</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI142733</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS105539</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AR075174</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 GM126893</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CoiStatement>Competing Interests Dr. Suzanne D. Vernon is affiliated and has a financial interest with The BioCollective, a company that provided the BioCollector, the collection kit used for at home stool collection discussed in this manuscript. No other authors have competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38979186</ArticleId><ArticleId IdType="pmc">PMC11230215</ArticleId><ArticleId IdType="doi">10.1101/2024.06.24.600378</ArticleId><ArticleId IdType="pii">2024.06.24.600378</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Mel S., Lim S. H., Tung M. L. &amp; Chng W.-J. Implications of Heterogeneity in Multiple Myeloma. BioMed Res. Int. 2014, 232546 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4102035</ArticleId><ArticleId IdType="pubmed">25101266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallstrom G., Anderson K. S. &amp; LaBaer J. Biomarker Discovery for Heterogeneous Diseases.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3842033</ArticleId><ArticleId IdType="pubmed">23462916</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyand C. M., McCarthy T. G. &amp; Goronzy J. J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J. Clin. Invest. 95, 2120&#x2013;2126 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC295811</ArticleId><ArticleId IdType="pubmed">7738179</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R. et al. Multi-&#x2018;omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients. Cell Host Microbe 31, 273&#x2013;287.e5 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353054</ArticleId><ArticleId IdType="pubmed">36758521</ArticleId></ArticleIdList></Reference><Reference><Citation>Giladi N., Mirelman A., Thaler A. &amp; Orr-Urtreger A. A Personalized Approach to Parkinson&#x2019;s Disease Patients Based on Founder Mutation Analysis. Front. Neurol. 7, (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861838</ArticleId><ArticleId IdType="pubmed">27242656</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S. M. et al. Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study. Infect. Dis. Ther. 12, 1189&#x2013;1203 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113728</ArticleId><ArticleId IdType="pubmed">37074613</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki T. &amp; Sano H. Predicting Treatment Responses and Disease Progression in Myeloma using Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels. Leuk. Lymphoma 44, 1275&#x2013;1279 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12952219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hare P. J., LaGree T. J., Byrd B. A., DeMarco A. M. &amp; Mok W. W. K. Single-Cell Technologies to Study Phenotypic Heterogeneity and Bacterial Persisters. Microorganisms 9, 2277 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8620850</ArticleId><ArticleId IdType="pubmed">34835403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R. M., Haggerty S. &amp; Herman W. H. HbA1c for the Diagnosis of Diabetes and Prediabetes: Is It Time for a Mid-Course Correction? J. Clin. Endocrinol. Metab. 95, 5203&#x2013;5206 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999978</ArticleId><ArticleId IdType="pubmed">21131541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W. et al. Longitudinal multi-omics of host&#x2013;microbe dynamics in prediabetes. Nature 569, 663&#x2013;671 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6666404</ArticleId><ArticleId IdType="pubmed">31142858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S. et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. Cancer Res. Treat. 52, 335&#x2013;350 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176962</ArticleId><ArticleId IdType="pubmed">32178489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeeshan S., Xiong R., Liang B. T. &amp; Ahmed Z. 100 years of evolving gene&#x2013;disease complexities and scientific debutants. Brief. Bioinform. 21, 885&#x2013;905 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30972412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C. T., Arcos-Burgos M. &amp; Lidbury B. A. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics 9, 91 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E. et al. Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Diagnostics 9, 73 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787691</ArticleId><ArticleId IdType="pubmed">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor N. et al. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome. Anesthesiol. Pain Med. 11, e113629 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438707</ArticleId><ArticleId IdType="pubmed">34540633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N. &amp; Zabaleta A. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Front. Immunol. 12, 656797 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Su R. et al. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine. mBio 11, 10.1128/mbio.02540-20 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02540-20</ArticleId><ArticleId IdType="pmc">PMC7683398</ArticleId><ArticleId IdType="pubmed">33203755</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D. E. et al. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2. Emerg. Microbes Infect. 9, 900&#x2013;902 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241448</ArticleId><ArticleId IdType="pubmed">32380903</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S. J., Corrales-Medina V. &amp; Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther. Adv. Infect. Dis. 8, 20499361211009385 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken P. A. et al. Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study. Eur. Arch. Psychiatry Clin. Neurosci. (2023) doi:10.1007/s00406-023-01661-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01661-3</ArticleId><ArticleId IdType="pubmed">37587244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretherick A. D. et al. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study. NIHR Open Res. 3, 20 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10593357</ArticleId><ArticleId IdType="pubmed">37881452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J. &amp; Lin J.-M. S. Healthcare Utilization in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Analysis of US Ambulatory Healthcare Data, 2000&#x2013;2009. Front. Pediatr. 7, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527768</ArticleId><ArticleId IdType="pubmed">31139604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y. &amp; Zhu Z. Editorial: Retrieving meaningful patterns from big biomedical data with machine learning approaches. Front. Genet. 14, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064148</ArticleId><ArticleId IdType="pubmed">37007948</ArticleId></ArticleIdList></Reference><Reference><Citation>Leelatian N. et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. eLife 9, e56879 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340505</ArticleId><ArticleId IdType="pubmed">32573435</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q. et al. The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome. Cell Host Microbe 32, 651&#x2013;660.e4 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38657605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A. R., van Goor H., Faber K. N. &amp; Dijkstra G. Clinical Value of Multiomics-Based Biomarker Signatures in Inflammatory Bowel Diseases: Challenges and Opportunities. Clin. Transl. Gastroenterol. 14, e00579 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10371325</ArticleId><ArticleId IdType="pubmed">36881831</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcos-Zambrano L. J. et al. Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment. Front. Microbiol. 12, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962872</ArticleId><ArticleId IdType="pubmed">33737920</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C. et al. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS. Cell Host Microbe 31, 288&#x2013;304.e8 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10183837</ArticleId><ArticleId IdType="pubmed">36758522</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers R. P. H. et al. Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome. J. Transl. Med. 18, 448 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7690002</ArticleId><ArticleId IdType="pubmed">33243243</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A. et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight 7, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9090259</ArticleId><ArticleId IdType="pubmed">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Che X. et al. Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Int. J. Mol. Sci. 23, 7906 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9320121</ArticleId><ArticleId IdType="pubmed">35887252</ArticleId></ArticleIdList></Reference><Reference><Citation>Li&#xf1;ares-Blanco J., Fernandez-Lozano C., Seoane J. A. &amp; L&#xf3;pez-Campos G. Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes. Front. Microbiol. 13, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9157387</ArticleId><ArticleId IdType="pubmed">35663898</ArticleId></ArticleIdList></Reference><Reference><Citation>He F. et al. Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites. J. Med. Internet Res. 26, e41065 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11009843</ArticleId><ArticleId IdType="pubmed">38546730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawken S. et al. External validation of machine learning models including newborn metabolomic markers for postnatal gestational age estimation in East and South-East Asian infants. Preprint at 10.12688/gatesopenres.13131.2 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.13131.2</ArticleId><ArticleId IdType="pmc">PMC8160452</ArticleId><ArticleId IdType="pubmed">34104876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora-Ortiz M., Trichard M., Oregioni A. &amp; Claus S. P. Thanatometabolomics: introducing NMR-based metabolomics to identify metabolic biomarkers of the time of death. Metabolomics 15, 37 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6476858</ArticleId><ArticleId IdType="pubmed">30834988</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian R. et al. Metabolomic profiles associated with all-cause mortality in the Women&#x2019;s Health Initiative. Int. J. Epidemiol. 49, 289&#x2013;300 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124492</ArticleId><ArticleId IdType="pubmed">31651959</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Ren M. &amp; Li Q. 1H NMR-Based Metabolomics Reveals the Intrinsic Interaction of Age, Plasma Signature Metabolites, and Nutrient Intake in the Longevity Population in Guangxi, China. Nutrients 14, 2539 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9227029</ArticleId><ArticleId IdType="pubmed">35745269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondoh H. &amp; Kameda M. Metabolites in aging and aging-relevant diseases: Frailty, sarcopenia and cognitive decline. Geriatr. Gerontol. Int. 24, 44&#x2013;48 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">37837183</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng S., Shen Y., Wang M. &amp; Zhang J. Serum and CSF Metabolites in Stroke-Free Patients Are Associated With Vascular Risk Factors and Cognitive Performance. Front. Aging Neurosci. 12, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387721</ArticleId><ArticleId IdType="pubmed">32774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerler P., Vollenweider F. X. &amp; Preller K. H. A neurobiological perspective on social influence: Serotonin and social adaptation. J. Neurochem. 162, 60&#x2013;79 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9322456</ArticleId><ArticleId IdType="pubmed">35274296</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomrenze M. B., Paliarin F. &amp; Maiya R. Friend of the Devil: Negative Social Influences Driving Substance Use Disorders. Front. Behav. Neurosci. 16, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8866771</ArticleId><ArticleId IdType="pubmed">35221948</ArticleId></ArticleIdList></Reference><Reference><Citation>Laslett A.-M. Commentary on Bischof et al.: Empirical and conceptual paradigms for studying secondary impacts of a person&#x2019;s substance use. Addiction 117, 3148&#x2013;3149 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9828476</ArticleId><ArticleId IdType="pubmed">36216593</ArticleId></ArticleIdList></Reference><Reference><Citation>Carco C. et al. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front. Cell. Infect. Microbiol. 10, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7509092</ArticleId><ArticleId IdType="pubmed">33014892</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffouri G. B. et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat. Commun. 10, 2012 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494866</ArticleId><ArticleId IdType="pubmed">31043597</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S., Wu X., Hu X., Wang T. &amp; Jin F. Recognizing Depression from the Microbiota&#x2013;Gut&#x2013;Brain Axis. Int. J. Mol. Sci. 19, 1592 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6032096</ArticleId><ArticleId IdType="pubmed">29843470</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Tu H. &amp; Chen T. The Microbiota&#x2013;Gut&#x2013;Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect. Nutrients 14, 2081 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9144102</ArticleId><ArticleId IdType="pubmed">35631224</ArticleId></ArticleIdList></Reference><Reference><Citation>Topan R. &amp; Scott S. M. Sleep: An Overlooked Lifestyle Factor in Disorders of Gut-Brain Interaction. Curr. Treat. Options Gastroenterol. 21, 435&#x2013;446 (2023).</Citation></Reference><Reference><Citation>Moens de Hase E. et al. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention. Diabetologia 67, 333&#x2013;345 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10789671</ArticleId><ArticleId IdType="pubmed">37897566</ArticleId></ArticleIdList></Reference><Reference><Citation>Amabebe E., Robert F. O., Agbalalah T. &amp; Orubu E. S. F. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br. J. Nutr. 123, 1127&#x2013;1137 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32008579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh P. et al. Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and &#x3b1;-PBP, in human urine. Drug Test. Anal. 12, 1442&#x2013;1451 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32621389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.-H. et al. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review. Eur. J. Med. Res. 29, 148 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10908121</ArticleId><ArticleId IdType="pubmed">38429822</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenoir M. et al. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567499</ArticleId><ArticleId IdType="pubmed">33054518</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. 105, 16731&#x2013;16736 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575488</ArticleId><ArticleId IdType="pubmed">18936492</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu&#xe9;vrain E. et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn&#x2019;s disease. Gut 65, 415&#x2013;425 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136800</ArticleId><ArticleId IdType="pubmed">26045134</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel S. et al. Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii. mBio 6, 10.1128/mbio.00300-15 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00300-15</ArticleId><ArticleId IdType="pmc">PMC4453580</ArticleId><ArticleId IdType="pubmed">25900655</ArticleId></ArticleIdList></Reference><Reference><Citation>Vital M., Howe A. C. &amp; Tiedje J. M. Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data. mBio 5, e00889&#x2013;14 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3994512</ArticleId><ArticleId IdType="pubmed">24757212</ArticleId></ArticleIdList></Reference><Reference><Citation>Recharla N., Geesala R. &amp; Shi X.-Z. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review. Nutrients 15, 2275 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10221771</ArticleId><ArticleId IdType="pubmed">37242159</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro C. R. A. V. et al. In Vitro Antimicrobial Activity and Probiotic Potential of Bifidobacterium and Lactobacillus against Species of Clostridium. Nutrients 11, 448 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412307</ArticleId><ArticleId IdType="pubmed">30795551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Li G. &amp; Deng Y. Engineering Escherichia coli for Glutarate Production as the C5 Platform Backbone. Appl. Environ. Microbiol. 84, e00814&#x2013;18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070760</ArticleId><ArticleId IdType="pubmed">29858204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen-Lefebvre A. T., Selzner N., Wrana J. L. &amp; Bhat M. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease. FASEB J. 35, e21570 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33831275</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M. A., Gupta A., Sastry J. L. N. &amp; Ahmad S. Hepatoprotective potential of kumaryasava and its concentrate against CCl4-induced hepatic toxicity in Wistar rats. J. Pharm. Bioallied Sci. 7, 297&#x2013;299 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678989</ArticleId><ArticleId IdType="pubmed">26681887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.-S. Roles of Diet-Associated Gut Microbial Metabolites on Brain Health: Cell-to-Cell Interactions between Gut Bacteria and the Central Nervous System. Adv. Nutr. 15, 100136 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10694655</ArticleId><ArticleId IdType="pubmed">38436218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebeaud J., Peter B. &amp; Pot C. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation. Int. J. Mol. Sci. 23, 10128 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9456539</ArticleId><ArticleId IdType="pubmed">36077526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S. et al. Gut microbiome-related metabolites in plasma are associated with general cognition. Alzheimers Dement. 17, e056142 (2021).</Citation></Reference><Reference><Citation>Ahmed Z., Zeeshan S., Xiong R. &amp; Liang B. T. Debutant iOS app and gene-disease complexities in clinical genomics and precision medicine. Clin. Transl. Med. 8, e26 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778157</ArticleId><ArticleId IdType="pubmed">31586224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Z., Zeeshan S., Xiong R. &amp; Liang B. T. PAS-Gen: Guide to iOS app with gene-disease.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778157</ArticleId><ArticleId IdType="pubmed">31586224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Z., Wan S., Zhang F. &amp; Zhong W. Artificial intelligence for omics data analysis. BMC Methods 1, 4 (2024).</Citation></Reference><Reference><Citation>Ahmed Z., Mohamed K., Zeeshan S. &amp; Dong X. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database J. Biol. Databases Curation 2020, baaa010 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078068</ArticleId><ArticleId IdType="pubmed">32185396</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S. M. &amp; Hanson M. R. Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology. Metabolites 8, 90 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315598</ArticleId><ArticleId IdType="pubmed">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.-J. &amp; Son C.-G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 18, 289 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Barupal D. K., Levine S. M. &amp; Hanson M. R. Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids. Metabolites 10, 34 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7023305</ArticleId><ArticleId IdType="pubmed">31947545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Lav&#xed;n M. Holistic Treatment of Fibromyalgia Based on Physiopathology: An Expert Opinion. JCR J. Clin. Rheumatol. 26, 204 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32568952</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y. et al. The plasma metabolome of long COVID patients two years after infection. Sci. Rep. 13, 12420 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal M., Elzembely H. I. &amp; Said O. M. Letter to the Editor: &amp;ldquo;Self-Reported Student Awareness and Prevalence of Computer Vision Syndrome During COVID-19 Pandemic at Al-Baha University&amp;rdquo; [Letter]. Clin. Optom. 14, 193&#x2013;194 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9578492</ArticleId><ArticleId IdType="pubmed">36267876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedeh F. B. et al. The correlation between self-reported hand eczema and clinically based diagnosis in professional cleaners. Contact Dermatitis cod.14611 (2024) doi:10.1111/cod.14611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cod.14611</ArticleId><ArticleId IdType="pubmed">38845162</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L. A., Yoo S. &amp; Bhatia S. Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chronic Illn. 18, 901&#x2013;910 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9152619</ArticleId><ArticleId IdType="pubmed">34541918</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson M. R. The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome. PLOS Pathog. 19, e1011523 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10434940</ArticleId><ArticleId IdType="pubmed">37590180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamine S., Gerth-Guyette E., Faulx D., Green B. B. &amp; Ginsburg A. S. Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review. J. Med. Internet Res. 17, e3951 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376208</ArticleId><ArticleId IdType="pubmed">25803266</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark N. M. Management of Chronic Disease by Patients. Annu. Rev. Public Health 24, 289&#x2013;313 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12415147</ArticleId></ArticleIdList></Reference><Reference><Citation>Derman I. D. et al. High-throughput bioprinting of the nasal epithelium using patient-derived nasal epithelial cells. Biofabrication 15, 044103 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10424246</ArticleId><ArticleId IdType="pubmed">37536321</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming E. et al. Cultivation of common bacterial species and strains from human skin, oral, and gut microbiota. BMC Microbiol. 21, 278 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515726</ArticleId><ArticleId IdType="pubmed">34649516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Cislo P., Cappelleri J. C., Hlavacek P. &amp; DiBonaventura M. Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study. BMC Med. Res. Methodol. 23, 18 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843888</ArticleId><ArticleId IdType="pubmed">36647031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynn J. V., Buchman L. K., Breuler C. J. &amp; Buchman S. R. Surgical Timing and Neurocognitive Development among Patients with Craniosynostosis: Analysis of Confounders. Plast. Reconstr. Surg. 151, 821 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36728531</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhan E. et al. Perturbation of Effector and Regulatory T Cell Subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 2019.12.23.887505 10.1101/2019.12.23.887505v1 (2019) doi:10.1101/2019.12.23.887505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2019.12.23.887505v1</ArticleId><ArticleId IdType="doi">10.1101/2019.12.23.887505</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumina A. et al. Clinical Profile and Aspects of Differential Diagnosis in Patients with ME/CFS from Latvia. Medicina (Mex.) 57, 958 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8467618</ArticleId><ArticleId IdType="pubmed">34577881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubcevik N. et al. Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis. Front. Med. 7, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472530</ArticleId><ArticleId IdType="pubmed">32974369</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa G. G., Pereira A. R. &amp; Carvalho A. S. Pericardite l&#xfa;pica: dor tor&#xe1;cica e febre em tempos de COVID-19. Rev. Port. Med. Geral E Fam. 38, 300&#x2013;4 (2022).</Citation></Reference><Reference><Citation>Vyas J., Muirhead N., Singh R., Ephgrave R. &amp; Finlay A. Y. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open 12, e058128 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9062824</ArticleId><ArticleId IdType="pubmed">35501074</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez A., Okoh A., Ko Y.-A. &amp; Wells B. Racial Differences in FMD. 2023.02.10.23285630 Preprint at 10.1101/2023.02.10.23285630 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.10.23285630</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivedi M. S. et al. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns. PLOS ONE 13, e0201066 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6056050</ArticleId><ArticleId IdType="pubmed">30036399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouquet J. et al. Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing. PLOS ONE 14, e0212193 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6428308</ArticleId><ArticleId IdType="pubmed">30897114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande A. et al. Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Sci. Rep. 10, 5267 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093502</ArticleId><ArticleId IdType="pubmed">32210306</ArticleId></ArticleIdList></Reference><Reference><Citation>Almenar-P&#xe9;rez E. et al. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation. Clin. Ther. 41, 675&#x2013;698 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30910331</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Taylor K., Kozubek J., Sardell J. &amp; Gardner S. Genetic risk factors for ME/CFS identified using combinatorial analysis. J. Transl. Med. 20, 598 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749644</ArticleId><ArticleId IdType="pubmed">36517845</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruana E. J., Roman M., Hern&#xe1;ndez-S&#xe1;nchez J. &amp; Solli P. Longitudinal studies. J. Thorac. Dis. 7, E537&#x2013;E540 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669300</ArticleId><ArticleId IdType="pubmed">26716051</ArticleId></ArticleIdList></Reference><Reference><Citation>White R. T. &amp; Arzi H. J. Longitudinal Studies: Designs, Validity, Practicality, and Value. Res. Sci. Educ. 35, 137&#x2013;149 (2005).</Citation></Reference><Reference><Citation>Aurora C., Cecilia A. &amp; Adina H. The Role of Diet in the Treatment of Chronic Diseases Case Study. ARS Medica Tomitana 27, 153&#x2013;156 (2021).</Citation></Reference><Reference><Citation>Therrien R. &amp; Doyle S. Role of training data variability on classifier performance and generalizability. in Medical Imaging 2018: Digital Pathology vol. 10581 58&#x2013;70 (SPIE, 2018).</Citation></Reference><Reference><Citation>Zhang B., Qin A. K., Pan H. &amp; Sellis T. A Novel DNN Training Framework via Data Sampling and Multi-Task Optimization. in 2020 International Joint Conference on Neural Networks (IJCNN) 1&#x2013;8 (2020). doi:10.1109/IJCNN48605.2020.9207329.</Citation></Reference><Reference><Citation>Lathan C., Spira J. L., Bleiberg J., Vice J. &amp; Tsao J. W. Defense Automated Neurobehavioral Assessment (DANA)-psychometric properties of a new field-deployable neurocognitive assessment tool. Mil. Med. 178, 365&#x2013;371 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23707818</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick H. E. &amp; Lathan C. E. From battlefield to home: a mobile platform for assessing brain health. mHealth 2, 30 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344163</ArticleId><ArticleId IdType="pubmed">28293603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. et al. Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients. J. Transl. Med. 18, 314 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429890</ArticleId><ArticleId IdType="pubmed">32799889</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/ChronicFatigue Syndrome, Board on the Health of Select Populations, &amp; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. (National Academies Press (US), Washington (DC), 2015).</Citation></Reference><Reference><Citation>Monica, 1776 Main Street Santa &amp; California 90401&#x2013;3208. 36-Item Short Form Survey (SF-36) Scoring Instructions. https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html.</Citation></Reference><Reference><Citation>Blanco-M&#xed;guez A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633&#x2013;1644 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10635831</ArticleId><ArticleId IdType="pubmed">36823356</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460&#x2013;2461 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20709691</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M. I., Huber W. &amp; Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W., Le S., Li Y. &amp; Hu F. SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation. PLOS ONE 11, e0163962 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051824</ArticleId><ArticleId IdType="pubmed">27706213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714082</ArticleId><ArticleId IdType="pubmed">34784344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla N. V., Bowyer K. W., Hall L. O. &amp; Kegelmeyer W. P. SMOTE: Synthetic Minority Over-sampling Technique. J. Artif. Intell. Res. 16, 321&#x2013;357 (2002).</Citation></Reference><Reference><Citation>He Haibo, Bai Yang, Garcia E. A., &amp; Shutao Li. ADASYN: Adaptive synthetic sampling approach for imbalanced learning. in 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence) 1322&#x2013;1328 (IEEE, Hong Kong, China, 2008). doi:10.1109/IJCNN.2008.4633969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/IJCNN.2008.4633969</ArticleId></ArticleIdList></Reference><Reference><Citation>Saripuddin M., Suliman A., Syarmila Sameon S. &amp; Jorgensen B. N. Random Undersampling on Imbalance Time Series Data for Anomaly Detection. in Proceedings of the 2021 4th International Conference on Machine Learning and Machine Intelligence 151&#x2013;156 (Association for Computing Machinery, New York, NY, USA, 2022). doi:10.1145/3490725.3490748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3490725.3490748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg S. &amp; Lee S.-I. A Unified Approach to Interpreting Model Predictions. Preprint at 10.48550/arXiv.1705.07874 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1705.07874</ArticleId></ArticleIdList></Reference><Reference><Citation>Abadi M. et al. TensorFlow: A system for large-scale machine learning. Preprint at 10.48550/arXiv.1605.08695 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1605.08695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F. et al. Scikit-learn: Machine Learning in Python. Preprint at 10.48550/arXiv.1201.0490 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1201.0490</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P. &amp; Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonov M. et al. igraph enables fast and robust network analysis across programming languages. Preprint at 10.48550/arXiv.2311.10260 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2311.10260</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo T. K. &amp; Li M. Y. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J. Chiropr. Med. 15, 155&#x2013;163 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelder J. A. &amp; Wedderburn R. W. M. Generalized Linear Models. J. R. Stat. Soc. Ser. Gen. 135, 370&#x2013;384 (1972).</Citation></Reference><Reference><Citation>Bakdash J. Z. &amp; Marusich L. R. Repeated Measures Correlation. Front. Psychol. 8, (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5383908</ArticleId><ArticleId IdType="pubmed">28439244</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C. Smoothing Spline ANOVA Models: R Package gss. Smoothing Spline ANOVA Models.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>